These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 34039838
1. Regression of Electrocardiographic Left Ventricular Hypertrophy After Transcatheter Aortic Valve Implantation for Aortic Stenosis. Tobe A, Tanaka A, Tokuda Y, Akita S, Fujii T, Miki Y, Furusawa K, Ishii H, Usui A, Murohara T. Circ J; 2021 Jun 25; 85(7):1093-1098. PubMed ID: 34039838 [Abstract] [Full Text] [Related]
2. Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy After Transcatheter Aortic Valve Implantation: Insights from the OCEAN-TAVI Registry. Koga M, Izumo M, Yoneyama K, Akashi YJ, Yashima F, Tada N, Yamawaki M, Shirai S, Naganuma T, Yamanaka F, Ueno H, Tabata M, Mizutani K, Takagi K, Watanabe Y, Yamamoto M, Hayashida K, OCEAN-TAVI Investigators. Am J Cardiol; 2023 Oct 01; 204():130-139. PubMed ID: 37541149 [Abstract] [Full Text] [Related]
3. Clinical value of regression of electrocardiographic left ventricular hypertrophy after aortic valve replacement. Yamabe S, Dohi Y, Higashi A, Kinoshita H, Sada Y, Hidaka T, Kurisu S, Shiode N, Kihara Y, HERO (Hiroshima Heart Study Group) Investigators. Heart Vessels; 2016 Sep 01; 31(9):1497-503. PubMed ID: 26531830 [Abstract] [Full Text] [Related]
4. Prognostic impact of electrocardiographic left ventricular hypertrophy following transcatheter aortic valve replacement. Tanaka T, Yahagi K, Asami M, Ninomiya K, Kikushima H, Okuno T, Horiuchi Y, Yuzawa H, Komiyama K, Tanaka J, Yokozuka M, Miura S, Aoki J, Tanabe K. J Cardiol; 2021 Apr 01; 77(4):346-352. PubMed ID: 33455846 [Abstract] [Full Text] [Related]
5. Update on the clinical impact of mild aortic regurgitation after transcatheter aortic valve implantation: Insights from the Japanese multicenter OCEAN-TAVI registry. Yoshijima N, Yanagisawa R, Hase H, Tanaka M, Tsuruta H, Shimizu H, Fukuda K, Naganuma T, Mizutani K, Araki M, Tada N, Yamanaka F, Shirai S, Tabata M, Ueno H, Takagi K, Higashimori A, Watanabe Y, Yamamoto M, Hayashida K, OCEAN-TAVI investigators. Catheter Cardiovasc Interv; 2020 Jan 01; 95(1):35-44. PubMed ID: 30977256 [Abstract] [Full Text] [Related]
8. The relationship between electrocardiographic left ventricular hypertrophy criteria and echocardiographic mass in patients undergoing transcatheter aortic valve replacement. Sjöberg S, Sundh F, Schlegel T, Maynard C, Rück A, Wagner G, Ugander M. J Electrocardiol; 2015 Jan 01; 48(4):630-6. PubMed ID: 25865909 [Abstract] [Full Text] [Related]
9. Implication of Different ECG Left Ventricular Hypertrophy in Patients Undergoing Transcatheter Aortic Valve Replacement. Yang Y, Ahn JM, Kang DY, Ko E, Kim S, Kim TO, Kim JH, Lee J, Lee SA, Kim DH, Kim HJ, Kim JB, Choo SJ, Park SJ, Park DW. J Am Heart Assoc; 2022 Feb 15; 11(4):e023647. PubMed ID: 35112886 [Abstract] [Full Text] [Related]
11. Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries. Gonzales H, Douglas PS, Pibarot P, Hahn RT, Khalique OK, Jaber WA, Cremer P, Weissman NJ, Asch FM, Zhang Y, Gertz ZM, Elmariah S, Clavel MA, Thourani VH, Daubert M, Alu MC, Leon MB, Lindman BR. JACC Cardiovasc Interv; 2020 Jun 08; 13(11):1329-1339. PubMed ID: 32499024 [Abstract] [Full Text] [Related]
12. Prognostic implications of residual left ventricular hypertrophy and systolic dysfunction in aortic stenosis following transcatheter aortic valve replacement. Pedersen ALD, Povlsen JA, Rasmussen VG, Frederiksen CA, Christiansen EH, Terkelsen CJ, Vase H, Poulsen SH. Int J Cardiovasc Imaging; 2023 Jan 08; 39(1):13-22. PubMed ID: 36598683 [Abstract] [Full Text] [Related]
13. Absence of electrocardiographic left ventricular hypertrophy in patients undergoing Transcatheter aortic valve replacement is associated with increased mortality. Zhang R, Jou S, Cao Y, Keller K, Xiao E, de La Rosa A, DeLago A, El-Hajjar M, Torosoff M. J Electrocardiol; 2020 Jan 08; 63():12-16. PubMed ID: 33017756 [Abstract] [Full Text] [Related]
16. Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation. Scully PR, Patel KP, Treibel TA, Thornton GD, Hughes RK, Chadalavada S, Katsoulis M, Hartman N, Fontana M, Pugliese F, Sabharwal N, Newton JD, Kelion A, Ozkor M, Kennon S, Mullen M, Lloyd G, Menezes LJ, Hawkins PN, Moon JC. Eur Heart J; 2020 Aug 01; 41(29):2759-2767. PubMed ID: 32267922 [Abstract] [Full Text] [Related]
18. Determinants of Left Ventricular Mass Regression in Patients with Severe Symptomatic Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation. Weissler-Snir A, Shapira Y, Sagie A, Kazum S, Assali A, Vaknin-Assa H, Bental T, Codner P, Orvin K, Kornowski R, Vaturi M. J Heart Valve Dis; 2015 May 01; 24(3):272-9. PubMed ID: 26901894 [Abstract] [Full Text] [Related]
19. The cardiac computed tomography-derived extracellular volume fraction predicts patient outcomes and left ventricular mass reductions after transcatheter aortic valve implantation for aortic stenosis. Ishiyama M, Kurita T, Takafuji M, Sato K, Sugiura E, Nakamori S, Fujimoto N, Kitagawa K, Sakuma H, Dohi K. J Cardiol; 2023 May 01; 81(5):476-484. PubMed ID: 36503064 [Abstract] [Full Text] [Related]